Skip to content

ResMed RMD Financing Cash Flow

Financing Cash Flow at other companies

Eli Lilly logo
Eli LillyLLY
-$3.47B-351%
Inogen logo
InogenINGN
-$2.12M-109%
Five Point Holdings, Inc. logo
Five Point Holdings, Inc.FPH
-$48.2M-2,614%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
-$7.48M+91.5%
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
-$6.33M-271%
LivaNova logo
LivaNovaLIVN
-$94.25M-2,032%

Other financials

Income statement

See full
Revenue$1.4B+10.8%
Gross profit$891.0M+16.3%
Operating income$499.8M+17.3%
Net income$398.7M+9.2%
EPS (diluted)$2.74+10.5%

Balance sheet

See full
Cash & equivalents$1.7B+78.0%
Total debt$1.1B+29.8%
Total equity$6.5B+17.1%
Total assets$8.8B+16.1%

Cash flow

See full
Operating cash flow$554.1M-4.2%
CapEx$33.7M+61.8%
Free cash flow$520.5M-6.7%

Valuation

See full
Market cap$28.27B-19.1%
Enterprise value$27.71B-19.8%
P/E18.6×-6.3×
P/S5.1×-1.7×

Profitability

See full
Gross margin61.6%+2.8pp
Operating margin34.2%+2.1pp
Net margin27.4%+1.3pp
FCF margin31.7%+0.4pp

Returns & leverage

See full
Return on equity25.2%-0.6pp
Debt / equity0.2×0.0×
Current ratio-0.4×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ResMed's financing cash flow?
ResMed (RMD) reported financing cash flow of -$255.24M in Q1 2026.
How has ResMed's financing cash flow changed year-over-year?
ResMed's financing cash flow decreased by 77.2% year-over-year, from -$144.07M to -$255.24M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.